Top Markets
Coin of the day
BGI Genomics Co., Ltd. BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

300676
株式のランク #5740
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing... BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private organizations, both within China and across the globe. Its comprehensive service portfolio includes DNA, RNA, and tailored sequencing options. Additionally, it offers a suite of specialized genetic tests such as non-invasive prenatal testing (NIPT), reproductive health screening, and newborn genetic screening, alongside clinical exome sequencing. BGI Genomics also develops clinical and research-focused solutions for the field of oncology. During the COVID-19 pandemic, the firm provided crucial laboratory solutions for the detection and diagnosis of suspected cases, including SARS-CoV-2 IgM and IgG antibody detection kits, and real-time fluorescent RT-PCR kits. Their expertise spans numerous research domains, including but not limited to agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug development. Established in 1999, the company initially operated under the name Shenzhen BGI Medicine Co., Ltd. before officially changing to BGI Genomics Co., Ltd. in 2015. Its corporate headquarters are located in Shenzhen, China.
株価
$5.91
時価総額
$2.47B
変化(1日)
0.10%
変化(1年)
-22.57%
CN
取引 BGI Genomics Co., Ltd. (300676)

カテゴリー

BGI Genomics Co., Ltd.(300676)の株式分割履歴
BGI Genomics Co., Ltd.株(シンボル:300676)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 27, 2026に行われました。
Aug 27, 2026より前に購入された300676株は、現在0300676株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
8 x34
US
7 x47
US
0 -
CN
0 -
US
1 x1
US